Skip to main content
. 2020 Oct 28;15(10):e0240912. doi: 10.1371/journal.pone.0240912

Fig 3.

Fig 3

A. Survival free of composite endpoint in waitlisted candidates–Group 1, Group 2 with normal stress test & Group 2 with abnormal stress test; Time 0 –transplant recipient evaluation clinic. B. Survival free of composite endpoint in waitlisted candidates–Group 3a (DM+CVD-) and Group 3b (CVD+); Time 0 –transplant recipient evaluation clinic.